Video: Later-line care of ES-SCLC
Later-line management of ES-SCLC: Applying evidence to practice
Gain insights into the management of extensive-stage small-cell lung cancer (ES-SCLC) with Jacob Sands (Harvard Medical School, Boston, Massachusetts, USA) and Eric Singhi (The University of Texas MD Anderson Cancer Center, Houston, USA). In this accredited video, they discuss later-line management strategies, emerging evidence, and how clinical data can be applied in practice. Earn up to 20 minutes of effective education time upon successful completion.
Episode 1. Join thoracic oncologists Jacob Sands and Eric Singhi as they discuss later-line treatment strategies for ES-SCLC. They examine treatment selection and sequencing after first-line chemoimmunotherapy, emerging clinical evidence, ongoing unmet needs, and the role of clinical trials in improving outcomes for patients with relapsed disease. View transcript.
This video is part of an accredited series for oncologists, including thoracic oncologists, involved in the care of people with ES-SCLC.
A total of 1 CME credit is available across all three episodes, with each episode worth up to 20 minutes of effective education time. To claim credit for an episode, complete the associated knowledge quiz and evaluation form after viewing the video. To claim credit for more than one video, complete the full assessment.
Important note: If you are not logged into your Medthority account, please complete the full session without exiting your browser. If you exit before finishing, you’ll need to restart from the beginning. We recommend logging in to preserve your progress if you need to pause. Not a member yet? You can set up your free account in just a few minutes.
Developed independently by EPG Health, which received educational funding from Amgen awarded to EPG Health to help provide its healthcare professional members with access to the highest quality medical and scientific information, education and associated relevant content. EPG Health is an EBAC® Accredited Provider since 2026.
This activity has been accredited by the European Board for Accreditation of Continuing Education for Health Professionals (EBAC®) for 01:00 hours of effective education time.
EBAC® holds an agreement on mutual recognition of substantive equivalency with the US Accreditation Council for CME (ACCME) and the Royal College of Physicians and Surgeons of Canada, respectively.
Through an agreement between the European Board for Accreditation of Continuing Education for Health Professionals (EBAC®) and the American Medical Association, physicians may convert EBAC® External CME credits to AMA PRA Category 1 Credits™. Information on the process to convert EBAC® credit to AMA credit can be found on the AMA website. Other health care professionals may obtain from the AMA a certificate of having participated in an activity eligible for conversion of credit to AMA PRA Category 1 Credit™.
Through an agreement between the Royal College of Physicians and Surgeons of Canada and the European Board for Accreditation of Continuing Education for Health Professionals, Royal College MOC Section 1 credits are deemed to be substantively equivalent to EBAC CPD credits.
EBAC® is a member of the International Academy for CPD Accreditation (IACPDA), the World Federation for Medical Education (WFME) CPD Recognition Committee, and a partner member of the International Association of Medical Regulatory Authorities (IAMRA).